These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 12769162

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P.
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [Abstract] [Full Text] [Related]

  • 24. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 25. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P, Sheridan DJ, Zannad F, Dubourg O, Guéret P, Karpov Y, de Leeuw PW, Palma-Gamiz JL, Pessina A, Motz W, Degaute JP, Chastang C.
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [Abstract] [Full Text] [Related]

  • 26. Concluding remarks. Pursuit of the optimal outcome in hypertension.
    Hansson L.
    Clin Pharmacokinet; 1999 Oct; 37 Suppl 1():33-8. PubMed ID: 10491731
    [Abstract] [Full Text] [Related]

  • 27. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study.
    Emeriau JP, Knauf H, Pujadas JO, Calvo-Gomez C, Abate G, Leonetti G, Chastang C, European Study Investigators.
    J Hypertens; 2001 Feb; 19(2):343-50. PubMed ID: 11212979
    [Abstract] [Full Text] [Related]

  • 28. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.
    Ambrosioni E, Safar M, Degaute JP, Malin PL, MacMahon M, Pujol DR, de Cordoüe A, Guez D.
    J Hypertens; 1998 Nov; 16(11):1677-84. PubMed ID: 9856369
    [Abstract] [Full Text] [Related]

  • 29. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B.
    J Hum Hypertens; 2005 Jun; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.
    Waeber B, Rotaru C, Feihl F.
    Expert Opin Pharmacother; 2012 Jul; 13(10):1515-26. PubMed ID: 22725706
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE.
    Diabetes Res Clin Pract; 2008 Nov 13; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.